CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 9,375 shares (grant or award)
- 4 Grant or award Director acquired 14,285 shares (grant or award)
- 4 Grant or award Director acquired 30,357 shares (grant or award)
- 4 Grant or award Director acquired 21,428 shares (grant or award)
- 4 Grant or award Director acquired 19,196 shares (grant or award)
- 4 Open-market buy Chief Business Officer bought 20,000 shares at $2.46 ($49,200)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change
Page 7 of 22 · 427 filings